English

Interim report Q3 2023

Report this content

Growing demand for our solutions reflects the need for increased digitalization in health- and social care. The Nordic regions and municipalities need to invest more in IT than they have done historically. Cambio has the products and services to bridge the technical gap that the regions and municipalities face, and to enable tomorrow’s health- and social care. Together with our customers, we contribute to a better and healthier society.

Revenue in the third quarter amounted to 256.4 MSEK, representing a growth of 28.8%

Q3, July - September 2023

January - September 2023
  • Revenue amounted to 256.4 (199.1) MSEK in the third quarter, representing a growth of 28.8%
  • Adjusted EBITDA amounted to 70.8 (63.6) MSEK, representing a growth of 11.3%
  • Income before tax amounted to 2.8 (4.1) MSEK
  • Net income per share amounted to 0.02 (0.03) SEK
  • Revenue during January – September amounted to 773.5 (623.9) MSEK
  • Adjusted EBITDA amounted to 159.2 (182.8)
  • Income before tax amounted to -62.6 (42.9) MSEK
  • Net income per share was negative (0.22) SEK

For further information, please contact: 

Rami Avidan
CEO
+46 070 793 483 
rami.avidan@cambio.se

Johannes Fabó
CFO
+46 730 599 368
johannes.fabo@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.

Subscribe

Documents & Links